These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 39092253)

  • 1. Integrated network pharmacology and experimental verification to reveal the role of Shezhi Huangling Decoction against glioma by inactivating PI3K/Akt-HIF1A axis.
    Zhang X; Shao X; Bao Q; He L; Qi X
    Heliyon; 2024 Jul; 10(14):e34215. PubMed ID: 39092253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network pharmacology, molecular docking, and experimental verification reveal the mechanism of San-Huang decoction in treating acute kidney injury.
    Liu J; Li Z; Lao Y; Jin X; Wang Y; Jiang B; He R; Yang S
    Front Pharmacol; 2023; 14():1060464. PubMed ID: 36814499
    [No Abstract]   [Full Text] [Related]  

  • 3. The Chinese Medicine, Shezhi Huangling Decoction, Inhibits the Growth and Metastasis of Glioma Cells via the Regulation of miR-1298-5p/TGIF1 Axis.
    Liu X; Ju J; Liu Q; Zhu Z; Liu C
    Cancer Manag Res; 2020; 12():5677-5687. PubMed ID: 32765071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Verification of Erchen Decoction Plus Huiyanzhuyu Decoction in the Treatment of Laryngeal Squamous Cell Carcinoma Based on Network Pharmacology.
    Tan X; Luo Q; Hua Y; Zhou S; Peng G; Zhu R; Chen W; Li Y
    Integr Cancer Ther; 2024; 23():15347354241259182. PubMed ID: 38845538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of Sanhua Decoction in the Treatment of Ischemic Stroke Based on Network Pharmacology Methods and Experimental Verification.
    YingHuang ; Gao SS; Gong ZH; Li WJ; Xiao-junGou ; Sun JJ; Sun MJ
    Biomed Res Int; 2022; 2022():7759402. PubMed ID: 35097126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shenhuangdan decoction alleviates sepsis-induced lung injury through inhibition of GSDMD-mediated pyroptosis.
    Hu Y; He S; Xu X; Cui X; Wei Y; Zhao C; Ye H; Zhao J; Liu Q
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117047. PubMed ID: 37586442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems pharmacology and transcriptomics reveal the mechanisms of Sanhuang decoction enema in the treatment of ulcerative colitis with additional Candida albicans infection.
    Han Z; Tan X; Sun J; Wang T; Yan G; Wang C; Ma K
    Chin Med; 2021 Aug; 16(1):75. PubMed ID: 34376226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway.
    Tang Q; Cao H; Tong N; Liu Y; Wang W; Zou Y; Xu L; Zeng Z; Xu W; Yin Z; Ma W; Wang Q
    Phytomedicine; 2022 May; 99():154016. PubMed ID: 35278900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma.
    Zhao Z; Liu M; Long W; Yuan J; Li H; Zhang C; Tang G; Jiang W; Yuan X; Wu M; Liu Q
    Cancer Cell Int; 2021 Aug; 21(1):456. PubMed ID: 34454479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Radix Paeoniae Rubra Against Glioma.
    Zhu S; Jin Q; Zhang S; Song Z; Zhang S; Zhao Z
    Appl Biochem Biotechnol; 2024 Feb; ():. PubMed ID: 38381309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology and
    Zhang W; Zhang L; Wang WJ; Ma S; Wang M; Yao M; Li R; Li WW; Zhao X; Hu D; Ding Y; Wang J
    Pharm Biol; 2022 Dec; 60(1):119-130. PubMed ID: 34985385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isocucurbitacin B inhibits glioma growth through PI3K/AKT pathways and increases glioma sensitivity to TMZ by inhibiting hsa-mir-1286a.
    Han M; An J; Li S; Fan H; Wang L; Du Q; Du J; Yang Y; Song Y; Peng F
    Cancer Drug Resist; 2024; 7():16. PubMed ID: 38835342
    [No Abstract]   [Full Text] [Related]  

  • 15. Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K) / protein kinase B (Akt) pathway.
    Ye T; Chen R; Zhou Y; Zhang J; Zhang Z; Wei H; Xu Y; Wang Y; Zhang Y
    Bioengineered; 2022 May; 13(5):11646-11655. PubMed ID: 35505656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXM1-mediated NUF2 expression confers temozolomide resistance to human glioma cells by regulating autophagy via the PI3K/AKT/mTOR signaling pathway.
    Guo L; Wu Z
    Neuropathology; 2022 Oct; 42(5):430-446. PubMed ID: 35701983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network pharmacology analysis, molecular docking integrated experimental verification reveal β-sitosterol as the active anti-NSCLC ingredient of Polygonatum cyrtonema Hua by suppression of PI3K/Akt/HIF-1α signaling pathway.
    Cao W; Yuan F; Liu T; Yin R
    J Ethnopharmacol; 2024 Jun; 328():117900. PubMed ID: 38432577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated component identification, network pharmacology, and experimental verification revealed mechanism of Dendrobium officinale Kimura et Migo against lung cancer.
    Zhao Y; Zhu S; Li Y; Niu X; Shang G; Zhou X; Yin J; Bao B; Cao Y; Cheng F; Li Z; Wang R; Yao W
    J Pharm Biomed Anal; 2024 Jun; 243():116077. PubMed ID: 38460276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apigenin and Temozolomide Synergistically Inhibit Glioma Growth Through the
    Wang D; Wang Z; Dai X; Zhang L; Li M
    Cancer Biother Radiopharm; 2024 Mar; 39(2):125-132. PubMed ID: 33471569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.